Sittner & Nelson’s Boston Scientific BSX Stock Holding History

Sittner & Nelson’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.51K	Hold	129	–	–	﹤0.01%	485
2026 Q1	$8.1K	Hold	129	–	–	﹤0.01%	445
2025 Q4	$9.84K	Hold	129	–	–	﹤0.01%	406
2025 Q3	$12.6K	Hold	129	–	–	﹤0.01%	361
2025 Q2	$13.9K	Hold	129	–	–	0.01%	351
2025 Q1	$13K	Hold	129	–	–	0.01%	345
2024 Q4	$11.5K	Hold	129	–	–	0.01%	340
2024 Q3	$10.8K	Hold	129	–	–	﹤0.01%	336
2024 Q2	$9.93K	Hold	129	–	–	﹤0.01%	345
2024 Q1	$8.84K	Hold	129	–	–	﹤0.01%	355
2023 Q4	$7.46K	Hold	129	–	–	﹤0.01%	364
2023 Q3	$6.81K	Hold	129	–	–	﹤0.01%	363
2023 Q2	$6.98K	Hold	129	–	–	﹤0.01%	370
2023 Q1	$6.45K	Buy	+129	New	+$6.08K	﹤0.01%	385

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sittner & Nelson's BSX Position: Q2 2026 in Review

Sittner & Nelson held its Boston Scientific (BSX) position steady in Q2 2026 at 129 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Sittner & Nelson first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $13.9K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Sittner & Nelson held 129 shares of Boston Scientific worth $5.51K as of Q2 2026.
Sittner & Nelson left its Boston Scientific share count unchanged in Q2 2026.
Boston Scientific made up ﹤0.01% of Sittner & Nelson's portfolio in Q2 2026, its #485 holding.
Sittner & Nelson first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
Sittner & Nelson's Boston Scientific position peaked at $13.9K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.